Shilpa Pharma Lifesciences Limited, Unit-1, Received EIR from USFDA

Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited, Unit-1 received EIR from USFDA and the site is classified as VAI. The inspection was carried out at unit-1 by USFDA between March 3-7, 2025.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 694.15 as compared to the previous close of Rs. 668.70. The total number of shares traded during the day was 5368 in over 478 trades.

The stock hit an intraday high of Rs. 705.95 and intraday low of 670.50. The net turnover during the day was Rs. 3710707.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 Pharmaceuticals ShilpaPharmaLifesciences Unit1 USFDA EIR